Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Prostatic Neoplasms × Menogaril × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Prednisone 90 Docetaxel 77 Leuprolide 68 enzalutamide 56 Abiraterone Acetate 55 bicalutamide 40 Goserelin 40 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 36 Radiotherapy 30 abiraterone 20 apalutamide 19 sipuleucel-T 18 luprolide acetate gel depot 18 gallium 68 PSMA-11 18 Gonadotropin-Releasing Hormone 18 Radiosurgery 16 Magnetic Resonance Spectroscopy 16 Triptorelin Pamoate 15 Androgen Antagonists 15 cabazitaxel 14 Radiotherapy, Intensity-Modulated 13 pembrolizumab 12 Prednisolone 12 Dexamethasone 12 Brachytherapy 12 cabozantinib 11 Radiation 11 Dutasteride 11 Carboplatin 11 radium Ra 223 dichloride 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02710422 2019-09-11

MMEP

University of Miami

Phase 2 Terminated

24 enrolled 14 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡